Chavez, J. C., Dickinson, M., Muñoz, J., Ulrickson, M. L., Thieblemont, C., Oluwole, O. O., Herrera, A. F., Ujjani, C. S., Lin, Y., Riedell, P. A., Kekre, N., Vos, S. D., Wulff, J., Williams, C. M., Winters, J., Kloos, I., Xu, H., Neelapu, S. S. (2025). Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study. Blood. https://doi.org/10.1182/blood.2024027347